Table 2.

Summary of cases and pregnancy outcomes with the use of eculizumab and anticoagulation therapy (the median values are stated for laboratory results)

Case number	Period	Laboratory tests
		WBC (109/L)	RBC (1012/L)	HGB (g/L)	PLT (109/L)	Total BILI (umol/L)	LDH (U/L)
1	Baseline	3.41	3.26	107	134	14	NA
	In pregnancy	3.25	2.33	83	33	24.1	545
	Postpartum	3.82	2.49	90	40	-	394
2	Baseline	4	2.90	99.5	29.5	9	281
	In pregnancy 2.1	8.37	3.47	105.5	183	6.55	650
	Postpartum 2.1	ND	ND	ND	ND	ND	ND
	In pregnancy 2.2	7.88	3.84	111	230	7.5	596
	Postpartum 2.2	8.2	3.77	111	212	7.5	596
	Postpartum 2.3	-	-	130	205	4	382
3	Baseline	3.89	3.33	114.5	131	69.5	921
	In pregnancy 3.1	5.06	2.80	87	45	15	508
	Postpartum 3.1	ND	ND	ND	ND	ND	ND
4	Baseline	NB	NB	NB	NB	NB	NB
	In pregnancy 4.1	2.44	2.52	96.5	52	22.6	1603.5
	Postpartum 4.1	2.00	2.46	88	61	22	ND
	In pregnancy 4.2	2.15	3.21	91	107	14	1133
	Postpartum 4.2	2.01	3.32	90	99	12	ND

WBC – White blood cells; RBC – Red blood cells; HGB – Hemoglobin; PLT – Platelets; BILI – Bilirubin; LDH – Lactic dehydrogenase; ND – Not done; NB – No baseline